All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Noninvasive depression device player Neuronetics Inc. has priced an IPO that hits the trinity of positive deal indicators: strong first-day upside, pricing above the anticipated range and increasing the number of shares offered. The Malvern, Pa.-based company saw its shares climb 63 percent on the first day of trading after offering 5.5 million shares, up from the expected 5 million. It priced the offering at $17 per share, above the anticipated range of $14 to $16.